Pfizer (PFE) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the ...

Pfizer (PFE 0.77%) made a fortune thanks to its work in the COVID-19 market. In 2022, it became the first company in the ...

The stock exceeded the S&P 500 ... The investment community will be paying close attention to the earnings performance of Pfizer in its upcoming release. The company is slated to reveal its ...

MRNA stock Vs. PFE stock YTD performance (as of 31 Aug 21). Therefore, with both companies having their fair share of success in the COVID-19 market, we are rather surprised (although as MRNA ...

Three Motley Fool contributors believe they've identified fantastic dividend stocks to buy and hold for the next decade. Here's why they chose Abbott Laboratories ( ABT -1.00%), AbbVie ( ABBV 2.86%), ...

In this note, we discuss Pfizer’s stock performance, key takeaways from its recent results, and valuation. PFE stock has seen a decline of 15% from levels of $35 in early January 2021 to around ...

Let’s understand the company’s strengths and weaknesses to better analyze how to play PFE’s stock in the post-earnings scenario. Sales of PFE’s COVID Products Decline With the end of the ...